These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 37386635)
1. Decreased level of serum NT-proCNP associates with disease severity in COVID-19. Bojti I; Przewosnik AS; Luxenburger H; Hofmann M; Neumann-Haefelin C; Esser JS; Siegel PM; Maier A; Kovacs SB; Kardos L; Csanádi Z; Rieder M; Duerschmied D; Lother A; Bode C; Szabó GT; Czuriga D Respir Res; 2023 Jun; 24(1):174. PubMed ID: 37386635 [TBL] [Abstract][Full Text] [Related]
2. Prognostic value of circulating amino-terminal pro-C-type natriuretic peptide in critically ill patients. Koch A; Voigt S; Sanson E; Dückers H; Horn A; Zimmermann HW; Trautwein C; Tacke F Crit Care; 2011; 15(1):R45. PubMed ID: 21281508 [TBL] [Abstract][Full Text] [Related]
3. Circulating NT-proCNP predicts sepsis in multiple-traumatized patients without traumatic brain injury. Bahrami S; Pelinka L; Khadem A; Maitzen S; Hawa G; van Griensven M; Redl H Crit Care Med; 2010 Jan; 38(1):161-6. PubMed ID: 19730251 [TBL] [Abstract][Full Text] [Related]
4. Diagnostic value of NT-proCNP compared to NSE and S100B in cerebrospinal fluid and plasma of patients with sepsis-associated encephalopathy. Ehler J; Saller T; Wittstock M; Rommer PS; Chappell D; Zwissler B; Grossmann A; Richter G; Reuter DA; Nöldge-Schomburg G; Sauer M Neurosci Lett; 2019 Jan; 692():167-173. PubMed ID: 30423400 [TBL] [Abstract][Full Text] [Related]
5. N-Terminal Pro-C-Type Natriuretic Peptide: The Novel Marker in Selected Disease Units. Tomasiuk R Protein Pept Lett; 2022; 29(2):125-132. PubMed ID: 34823452 [TBL] [Abstract][Full Text] [Related]
6. Serial Evaluation of Abdominal Fluid and Serum Amino-terminal pro-C-type Natriuretic Peptide in Dogs with Septic Peritonitis. Guieu LV; Bersenas AM; Holowaychuk MK; Brisson BA; Weese JS J Vet Intern Med; 2015; 29(5):1300-6. PubMed ID: 26130056 [TBL] [Abstract][Full Text] [Related]
7. Comparative measurement of CNP and NT-proCNP in human blood samples: a methodological evaluation. Kuehnl A; Pelisek J; Bruckmeier M; Safi W; Eckstein HH J Negat Results Biomed; 2013 Apr; 12():7. PubMed ID: 23547980 [TBL] [Abstract][Full Text] [Related]
8. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial. Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543 [TBL] [Abstract][Full Text] [Related]
9. Prognostic value of N-terminal pro C-type natriuretic peptide in heart failure patients with preserved and reduced ejection fraction. Lok DJ; Klip IT; Voors AA; Lok SI; Bruggink-André de la Porte PW; Hillege HL; Jaarsma T; van Veldhuisen DJ; van der Meer P Eur J Heart Fail; 2014 Sep; 16(9):958-66. PubMed ID: 25082741 [TBL] [Abstract][Full Text] [Related]
10. Higher level of NT-proCNP in cerebrospinal fluid of patients with meningitis. Tomasiuk R; Lipowski D; Szlufik S; Peplinska K; Mikaszewska-Sokolewicz M Neurosci Lett; 2016 Feb; 614():29-32. PubMed ID: 26742639 [TBL] [Abstract][Full Text] [Related]
11. Blood serum levels of amino-terminal pro-C-type natriuretic peptide in patients with rheumatoid arthritis. Olewicz-Gawlik A; Trzybulska D; Grala P; Hrycaj P Adv Med Sci; 2010; 55(2):261-5. PubMed ID: 20934962 [TBL] [Abstract][Full Text] [Related]
12. Comparison of NT-proCNP and CNP plasma levels in heart failure, diabetes and cirrhosis patients. Del Ry S; Cabiati M; Stefano T; Catapano G; Caselli C; Prescimone T; Passino C; Emdin M; Giannessi D Regul Pept; 2011 Jan; 166(1-3):15-20. PubMed ID: 20800621 [TBL] [Abstract][Full Text] [Related]
13. Regional release and clearance of C-type natriuretic peptides in the human circulation and relation to cardiac function. Palmer SC; Prickett TC; Espiner EA; Yandle TG; Richards AM Hypertension; 2009 Sep; 54(3):612-8. PubMed ID: 19620509 [TBL] [Abstract][Full Text] [Related]
15. Serum NT-proCNP concentrations are elevated in patients with chronic liver diseases and associated with complications and unfavorable prognosis of cirrhosis. Koch A; Zimmermann HW; Baeck C; Schneider C; Yagmur E; Trautwein C; Tacke F Clin Biochem; 2012 Apr; 45(6):429-35. PubMed ID: 22285383 [TBL] [Abstract][Full Text] [Related]
16. Elevated level of serum human epididymis protein 4 (HE4) predicts disease severity and mortality in COVID-19 pneumonia. Sütő R; Pócsi M; Szabó Z; Fejes Z; Ivády G; Kerekes G; Fagyas M; Nagy A; Szentkereszty Z; Kappelmayer J; Nagy B BMC Pulm Med; 2023 Dec; 23(1):512. PubMed ID: 38104063 [TBL] [Abstract][Full Text] [Related]
17. Plasma Amino-Terminal Propeptide of C-Type Natriuretic Peptide Concentration in Normal-Weight and Obese Children. Topçu S; Özhan B; Alkan A; Akyol M; Şimşek Orhon F; Başkan S; Ulukol B; Berberoğlu M; Şıklar Z; Şatıroğlu Tufan NL; Tufan AÇ J Clin Res Pediatr Endocrinol; 2017 Dec; 9(4):308-314. PubMed ID: 28739556 [TBL] [Abstract][Full Text] [Related]
18. Serum NT-proCNP levels increased after initiation of GH treatment in patients with achondroplasia/hypochondroplasia. Kubota T; Wang W; Miura K; Nakayama H; Yamamoto K; Fujiwara M; Ohata Y; Tachibana M; Kitaoka T; Takakuwa S; Miyoshi Y; Namba N; Ozono K Clin Endocrinol (Oxf); 2016 Jun; 84(6):845-50. PubMed ID: 26814021 [TBL] [Abstract][Full Text] [Related]
19. Norwegian Coronavirus Disease 2019 (NO COVID-19) Pragmatic Open label Study to assess early use of hydroxychloroquine sulphate in moderately severe hospitalised patients with coronavirus disease 2019: A structured summary of a study protocol for a randomised controlled trial. Lyngbakken MN; Berdal JE; Eskesen A; Kvale D; Olsen IC; Rangberg A; Jonassen CM; Omland T; Røsjø H; Dalgard O Trials; 2020 Jun; 21(1):485. PubMed ID: 32503662 [TBL] [Abstract][Full Text] [Related]